Insider Transactions in Q1 2022 at La Jolla Pharmaceutical CO (LJPC)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
177
+1.93%
|
$531
$3.63 P/Share
|
|
Mar 31
2022
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
334
+2.78%
|
$1,002
$3.63 P/Share
|
|
Mar 15
2022
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
190
+2.11%
|
$570
$3.37 P/Share
|
|
Mar 15
2022
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
361
+3.09%
|
$1,083
$3.37 P/Share
|
|
Feb 28
2022
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
185
+2.1%
|
$555
$3.48 P/Share
|
|
Feb 28
2022
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
350
+3.09%
|
$1,050
$3.48 P/Share
|
|
Feb 15
2022
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
169
+1.97%
|
$507
$3.79 P/Share
|
|
Feb 15
2022
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
320
+2.92%
|
$960
$3.79 P/Share
|
|
Jan 31
2022
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,675
+16.86%
|
$5,025
$3.94 P/Share
|
|
Jan 31
2022
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,170
+28.8%
|
$12,510
$3.94 P/Share
|
|
Jan 14
2022
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
148
+2.2%
|
$592
$4.18 P/Share
|
|
Jan 14
2022
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
273
+4.26%
|
$1,092
$4.18 P/Share
|